Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer von YAN WU, ZHAOJING ZHONG, KOO, Henry, MANGALAMPALLI, Venkata R. M, LUDWIG, Dale L, TONRA, James R, HICKLIN, Daniel J, HUBER, James, BASSI, Rajiv, FINNERTY, Bridget, CORCORAN, Erik, HUILING LI, NAVARRO, Elizabeth, BALDERES, Paul, JIMENEZ, Xenia

Volltext

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeut... von Loizos, Nick, Xu, Yan, Huber, Jim, Liu, Meilin, Lu, Dan, Finnerty, Bridget, Rolser, Robin, Malikzay, Asra, Persaud, Anita, Corcoran, Erik, Deevi, Dhanvanthri S, Balderes, Paul, Bassi, Rajiv, Jimenez, Xenia, Joynes, Christopher J, Mangalampalli, Venkata R M, Steiner, Philipp, Tonra, James R, Wu, Yan, Pereira, Daniel S, Zhu, Zhenping, Ludwig, Dale L, Hicklin, Daniel J, Bohlen, Peter, Witte, Larry, Kussie, Paul

Volltext

Increased production of a secreted glycoprotein in engineered CHO cells through amplification of a transcription factor von MANGALAMPALLI, Venkata R. M, MOWRY, Mark C, LIPSCOMB, Matthew L, JAMES, Rohaizah I, JOHNSON, Alyssa K, KOMPALA, Dhinakar S

Volltext

A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity von Lu, Dan, Zhang, Haifan, Koo, Henry, Tonra, James, Balderes, Paul, Prewett, Marie, Corcoran, Eric, Mangalampalli, Venkata, Bassi, Rajiv, Anselma, Deborah, Patel, Dipa, Kang, Xiaoqiang, Ludwig, Dale L., Hicklin, Daniel J., Bohlen, Peter, Witte, Larry, Zhu, Zhenping

Volltext

CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines von Mangalampalli, Venkata R, Wycuff, Dyane, Chen, Mingzhong, Berlinger, David, Scheideman, Elizabeth H, Menon, Amritha, Fabozzi, Guilia, Hussain, Althaf, Schwartz, Richard M

Volltext